News Summary

Billy Evans, the partner of Theranos founder Elizabeth Holmes, is reportedly working on a new startup called Haemanthus, which aims to deliver ‘human health optimization’ through innovative blood testing methods. Haemanthus has developed a machine that uses lasers to analyze blood, saliva, and urine samples, initially targeting pet health before expanding to human diagnostics. The startup is seeking to raise over $50 million. Evans’ pitch has drawn comparisons to Theranos, which faced legal challenges due to fraudulent practices. Early Facebook investor Jim Breyer, among others, has declined to invest in the new venture.